or Try an Advanced Search...

    Selective Estrogen Receptor Degraders Stocks List

    Symbol Grade Name % Change
    GTHX B G1 Therapeutics, Inc. -3.26
    OLMA F Olema Pharmaceuticals, Inc. -3.15
    ZNTL F Zentalis Pharmaceuticals, Inc. -6.67
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Antiestrogens Biopharmaceutical Breast Cancer Estrogen Estrogen Receptor Her2 Her2/Neu Hormones Treatment Of Breast Cancer Cancer Drugs Epidermal Growth Factor Receptor Fulvestrant Receptor Positive Clinical Medicine Intracellular Receptors Medicine Metastatic Breast Cancer Molecule Therapeutics Protein Kinase Inhibitor

    Related ETFs - A few ETFs which own one or more of the above listed Selective Estrogen Receptor Degraders stocks.

    Symbol Grade Name Weight
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 1.4
    CNCR D Loncar Cancer Immunotherapy ETF 1.25
    SBIO D ALPS Medical Breakthroughs ETF 0.97
    XBI D SPDR S&P Biotech ETF 0.86
    LABU F Direxion Daily S&P Biotech Bull 3X Shares 0.6
    View all Selective Estrogen Receptor Degraders ETFs...
    Compare ETFs
    Compare BBC to CNCR Compare CNCR to XBI Compare SBIO to LABU

        Selective Estrogen Receptor Degraders Stocks Recent News

        Date Stock Title
        Apr 19 GTHX G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Shift From Loss To Profit
        Related Industries: Biotechnology
        Related Stock Lists: Antiestrogens Biopharmaceutical Breast Cancer Estrogen Estrogen Receptor Her2 Her2/Neu Hormones Treatment Of Breast Cancer Cancer Drugs Epidermal Growth Factor Receptor Fulvestrant Receptor Positive Clinical Medicine Intracellular Receptors Medicine Metastatic Breast Cancer Molecule Therapeutics Protein Kinase Inhibitor
        Selective Estrogen Receptor Degraders

        Selective Estrogen Receptor Degraders (SERDs) are a class of drugs that target the estrogen receptor and reduce its activity. They are used to treat hormone-dependent breast cancer and other estrogen-related conditions. SERDs work by blocking the binding of estrogen to its receptor, thus reducing the amount of estrogen that can activate the receptor. This can help reduce the growth of cancer cells that rely on estrogen for growth and survival.

        Browse All Tags